Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder
- PMID: 11353454
- DOI: 10.1002/ajmg.1326
Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder
Abstract
Recently, we have found an association between bipolar disorder patients who are excellent responders to lithium prophylaxis and a polymorphic marker located in the first intron of the phospholipase C-gamma1 gene (PLC-gamma1) [Turecki et al., 1998: Mol Psychiatry 3:534-538]. As this variant is not known to be functional, we searched for other markers within the coding region, using single-strand conformational polymorphism (SSCP) analysis. We have identified three polymorphic sites localized in three different exons of the PLC-gamma1 gene (exons 9, 26, 31). Variation studies of these potentially functional sites in a group of 133 bipolar patients with an excellent response to lithium prophylaxis and a comparison group of 99 healthy controls showed no difference in genotype distributions for exon 9 (chi-square = 1.41, df = 2, P = 0.49), exon 26 (chi-square = 2.26, df = 2, P = 0.13), or exon 31 (chi-square = 1.41, df = 2, P = 0.49). Similar results were observed for allele distributions. These results suggest that our previous findings were not the result of linkage disequilibrium with these variants.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder.Mol Psychiatry. 1998 Nov;3(6):534-8. doi: 10.1038/sj.mp.4000447. Mol Psychiatry. 1998. PMID: 9857980
-
The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism.Psychiatr Genet. 2001 Mar;11(1):41-3. doi: 10.1097/00041444-200103000-00008. Psychiatr Genet. 2001. PMID: 11409699
-
Variant GADL1 and response to lithium therapy in bipolar I disorder.N Engl J Med. 2014 Jan 9;370(2):119-28. doi: 10.1056/NEJMoa1212444. Epub 2013 Dec 25. N Engl J Med. 2014. PMID: 24369049
-
[Predictors of prophylactic response to lithium].Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Encephale. 2008. PMID: 18922242 Review. French.
-
Pharmacogenetics of lithium response in bipolar disorder.J Psychiatry Neurosci. 1999 Mar;24(2):154-8. J Psychiatry Neurosci. 1999. PMID: 10212559 Free PMC article. Review.
Cited by
-
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.Mol Diagn Ther. 2018 Aug;22(4):409-420. doi: 10.1007/s40291-018-0335-y. Mol Diagn Ther. 2018. PMID: 29790107 Review.
-
The promise and reality of pharmacogenetics in psychiatry.Psychiatr Clin North Am. 2010 Mar;33(1):181-224. doi: 10.1016/j.psc.2009.12.001. Psychiatr Clin North Am. 2010. PMID: 20159346 Free PMC article. Review.
-
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Hum Genomics Proteomics. 2010 Aug 3;2010:159761. doi: 10.4061/2010/159761. Hum Genomics Proteomics. 2010. PMID: 20981231 Free PMC article.
-
Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.Curr Psychiatry Rep. 2003 Dec;5(6):484-92. doi: 10.1007/s11920-003-0088-z. Curr Psychiatry Rep. 2003. PMID: 14609504 Review.
-
Role of phospholipase Cη1 in lateral habenula astrocytes in depressive-like behavior in mice.Exp Mol Med. 2025 Apr;57(4):872-887. doi: 10.1038/s12276-025-01432-1. Epub 2025 Apr 10. Exp Mol Med. 2025. PMID: 40204881 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous